IStent Inject Device Lowers IOP After Cataract Surgery in Glaucoma Patients

In patients with mild to moderate glaucoma and cataract, the second-generation iStent inject system, with two redesigned stents, reduces IOP more than cataract surgery alone, according to results of a new pivotal trial, as reported by Reuters.

“The most important finding is that the iStent inject, when done with cataract surgery, can improve the likelihood that unmedicated IOP is reduced by 20% or more compared to cataract surgery alone,” Dr. Pradeep Ramulu, a professor of ophthalmology at Johns Hopkins Wilmer Eye Institute in Baltimore, Maryland, told Reuters Health by email.

Read the full article.